Omnipaque (Iohexol)

Iohexol, the active ingredient in Omnipaque, is an iodinated contrast media presented as a strength/form for intravenous use. It enhances the visibility of vascular structures and organs during diagnostic imaging procedures. GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omnipaque is an iodinated contrast agent used in radiographic examinations that require enhanced visualization of internal structures.

- Cerebral angiography: improves detection of vascular abnormalities in the brain. - CT urography: provides detailed images of the urinary tract for stone and tumor assessment. - Cardiac catheterisation: delineates coronary artery patency and blockages. - Peripheral angiography: visualises limb vessels to guide interventions. - Abdominal CT: enhances contrast between organs and vasculature for lesion detection.

Adverse reactions to OmOmni‑cafe    ​     …   ...  … ​  … 

Common Side Effects: - Warm‑tasting ​      …  ...  ...  ...  ...  ...  ...  ...  t     t   t  t  t

Serious or Rare Side ...   t  t  t  t  t  t  eq  t  t  t  t  e  t  t  t  t  t  t t  t  t 

-   g   t  t \